Transcripts

Nektar Therapeutics (NKTR) earnings call transcripts

Earnings call transcripts for Nektar Therapeutics, with a summary, the guidance given, and what analysts pressed on.

Open NKTR in Gloom →
Nektar Therapeutics' chart, financials and news, free in your browser.Open NKTR in Gloom →
  • Q2 2026 earnings call

    Management framed RESPEG as a differentiated, upstream Treg therapy with broad label ambitions, emphasizing durability and first-line potential as its pivotal programs begin.

    Aug 13, 2026Confident0.77